Handbook of Contemporary Neuropharmacology: 3 Volume Set - Rilegato

Rilegato

ISBN 10: 0471660531 ISBN 13: 9780471660538

Casa editrice: Wiley-Interscience, 2007

Riassunto

Written and edited by recognized experts, this comprehensive reference is also available online via Wiley InterScience.

• Provides a readily accessible reference for students, professionals and libraries alike.
• Editors are recognized authorities in the neuropharmacology and science field.
• Comprehensive reference text for active junior and senior neurobiologists.
• Fills an important niche as a text between research publications and clinical applications.

The Handbook of Contemporary Neuropharmacology is an invaluable resource for principal investigators and working scientists in academia, government and industry. This three volume set it also of interest for academic physicians, postdoctoral fellows and residents, and all high-level graduate students.

Su questo libro

Recensione:

"...an admirable job of bringing together many aspects of neuropharmacology in one place...well worth your while to examine it." ( Journal of Medicinal Chemistry, September 20, 2007)

L'autore:

DAVID R. SIBLEY, PhD, is a Senior Investigator and Chief of the Molecular Neuropharmacology Section in the National Institute of Neurological Disorders and Stroke, National Institutes of Health. His laboratory is currently investigating the molecular, cellular, and biochemical properties of dopamine receptors and their role in neuronal signaling and pathophysiological states.

ISRAEL HANIN, PhD, is Professor and Chair Emeritus in the Department of Pharmacology at Loyola University Chicago. He formerly worked at the National Institute of Mental Health, Laboratory of Preclinical Pharmacology, and at the University of Pittsburgh Department of Psychiatry. Dr. Hanin's research has focused on cholinergic mechanisms, animal models for Alzheimer's disease, and the potential role of glycosaminoglycans in the treatment of Alzheimer's disease.

MICHAEL KUHAR, PhD, is currently a Candler Professor and Georgia Research Alliance Professor of Neuropharmacology at the Yerkes Primate Center at Emory University. He previously was a professor in the Neuroscience Department at Johns Hopkins, and a branch chief at the National Institute on Drug Abuse. Dr. Kuhar has published more than 800 articles, abstracts, book chapters, reviews, and patents.

PHIL SKOLNICK, PhD, D.Sc. (hon.), is Executive Vice President and Chief Scientific Officer for DOV Pharmaceutical, Inc. He was formerly a Lilly Fellow in Neuroscience and also served as Chief of the Laboratory of Neuroscience, National Institutes of Health.

Su questa edizione

• Editore: Wiley-Interscience
• Data di pubblicazione: 2007
• ISBN 10: 0471660531
• ISBN 13: 9780471660538
• Rilegatura: Copertina rigida
• Numero edizione: 1
• Numero di pagine: 3040
• Redattore: Sibley David R., Hanin Israel, Kuhar Michael, Skolnick Phil